Upgrade to SI Premium - Free Trial

LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40c

August 14, 2024 4:17 PM

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q2 EPS of ($0.40).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

Categories

Earnings

Next Articles